TITLE

New Codes Mean More Specificity For Barrett's Esophagus

PUB. DATE
June 2012
SOURCE
Gastroenterology Coding Alert;Jun2012, Vol. 14 Issue 6, p44
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the specifics for Barrett's esophagus. It stated that Barrett's esophagus is a common condition for patients with GERD (gastroesophageal reflux disease) and discusses on how to observe specificity based on dysplasia by using ICD-10 codes. It further discusses on the symptoms that encounter in the patient documentation including heartburn difficulty in swallowing and throwing up of blood.
ACCESSION #
75899639

 

Related Articles

  • Endoscopic eradication therapy can lead to strictures in patients with Barrett's esophagus.  // Hem/Onc Today;7/10/2012, Vol. 13 Issue 13, p30 

    The article discusses the results of a cohort study of 311 patients from U.S. tertiary referral centers that showed endoscopic eradication therapy can be a safe treatment strategy for patients with Barrett's esophagus, high-grade dysplasia and early adenocarcinoma but esophageal strictures can...

  • Laparoscopic Treatment of Obese Patients with Gastroesophageal Reflux Disease and Barrett's Esophagus: a Prospective Study. Braghetto, Italo; Korn, Owen; Csendes, Attila; Gutiérrez, Luis; Valladares, Héctor; Chacon, Max // Obesity Surgery;May2012, Vol. 22 Issue 5, p764 

    Background: Short-segment Barrett's esophagus (SSBE) or long-segment Barrett's esophagus (LSBE) is the consequence of chronic gastroesophageal reflux disease (GERD), which is frequently associated with obesity. Obesity is a significant risk factor for the development of GERD symptoms, erosive...

  • ESOPHAGUS.  // American Journal of Gastroenterology;Sep2007 Supplement 2, Vol. 102, pS119 

    The article presents abstracts on medical topics which include the use of photodynamic therapy in the treatment of Barrett's esophagus, the genetic factors of gastroesophageal reflux disease and a case on severe heartburn.

  • New guidelines for treatment options of Barrett's esophagus. TUCKER, DIANA // Medical Device Daily;5/16/2011, Vol. 15 Issue 94, p1 

    The article discusses multi-disciplinary approach to Barrett's esophagus (BE), as discussed at a symposium during Digestive Disease Week 2011. BE is a pre-cancerous condition associated with gastroesophageal reflux disease (GERD). During the symposium, use of several imaging techniques for...

  • Fibroblast-derived HB-EGF promotes Cdx2 expression in esophageal squamous cells. Rahman, Farzana B.; Kadowaki, Yasunori; Ishihara, Shunji; Tobita, Hiroshi; Imaoka, Hiroshi; Fukuhara, Hiroyuki; Aziz, Md Monowar; Furuta, Kenji; Amano, Yuji; Kinoshita, Yoshikazu // Laboratory Investigation (00236837);Jul2010, Vol. 90 Issue 7, p1033 

    The molecular basis of attaining columnar phenotype in Barrett's esophagus is poorly understood. One hypothesis states that factors locally produced by cells of mesenchymal origin in chronic reflux esophagitis induce metaplastic transformation. This study was performed to elucidate the factors...

  • Esophageal Adenocarcinoma Incidence in Individuals With Gastroesophageal Reflux: Synthesis and Estimates From Population Studies. Rubenstein, Joel H.; Scheiman, James M.; Sadeghi, Shahram; Whiteman, David; Inadomi, John M. // American Journal of Gastroenterology;Feb2011, Vol. 106 Issue 2, p254 

    OBJECTIVES:Recent advances in the management of Barrett's esophagus may kindle enthusiasm for screening for esophageal adenocarcinoma (EAC). Symptoms of gastroesophageal reflux disease (GERD) are recognized as relative risks for EAC. However, the absolute incidence of EAC in specific populations...

  • Development and Characterization of a Surgical Mouse Model of Reflux Esophagitis and Barrett's Esophagus. Pham, Thai; Genta, Robert; Spechler, Stuart; Souza, Rhonda; Wang, David // Journal of Gastrointestinal Surgery;Feb2014, Vol. 18 Issue 2, p234 

    Ideally, an animal model of Barrett's esophagus should recapitulate the human disease histologically and immunohistochemically, and be readily susceptible to genetic manipulation. We have developed such a model using a strain of mice commonly used for transgenic and knockout manipulations. We...

  • Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins. Goldberg, Aaron; Gerkin, Richard; Young, Michele // Digestive Diseases & Sciences;Jul2015, Vol. 60 Issue 7, p2058 

    Background: Barrett's esophagus (BE) is a complication of gastroesophageal reflux disease (GERD) that is a precursor to esophageal adenocarcinoma. There is limited information regarding whether medications can reduce the risk of developing BE. Aim: We analyzed medical records at a large veterans...

  • Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown, Craig; Lapin, Brittany; Wang, Chi; Goldstein, Jay; Linn, John; Denham, Woody; Haggerty, Stephen; Talamonti, Mark; Howington, John; Carbray, Joann; Ujiki, Michael; Brown, Craig S; Goldstein, Jay L; Linn, John G; Haggerty, Stephen P; Talamonti, Mark S; Howington, John A; Ujiki, Michael B // Surgical Endoscopy;Dec2015, Vol. 29 Issue 12, p3528 

    Background: It is unknown whether acid/reflux control prevents progression in Barrett's esophagus. In this study, we investigate whether medical or surgical control of reflux is associated with a decreased risk of progression to dysplasia/esophageal adenocarcinoma.Methods:...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics